PERSPECTA

News from every angle

Back to headlines

FDA Expedites Review of Psychedelic Drugs for Mental Health Treatment

The FDA has announced new steps to speed up research and review of psychedelic treatments for serious mental health conditions, with initial approvals potentially coming as early as summer, following an executive order.

25 Apr, 00:30 — 25 Apr, 00:30
PostShare